Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2007-01-23
2007-01-23
Weber, Jon (Department: 1653)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C530S353000
Reexamination Certificate
active
11006893
ABSTRACT:
Implants are used in combination with a fibrosis-inducing agent in order to induce fibrosis that may otherwise not occur when the implant is placed within an animal or increase fibrosis between the implant and the host tissue.
REFERENCES:
patent: 5162430 (1992-11-01), Rhee et al.
patent: 5204382 (1993-04-01), Wallace et al.
patent: 5213580 (1993-05-01), Slepian et al.
patent: 5290552 (1994-03-01), Sierra et al.
patent: 5310562 (1994-05-01), Margolin
patent: 5456693 (1995-10-01), Conston et al.
patent: 5611358 (1997-03-01), Suval
patent: 5612052 (1997-03-01), Shalaby
patent: 5614587 (1997-03-01), Rhee et al.
patent: 5752974 (1998-05-01), Rhee et al.
patent: 5843072 (1998-12-01), Furumoto et al.
patent: 5874500 (1999-02-01), Rhee et al.
patent: 5888546 (1999-03-01), Ji et al.
patent: 6096309 (2000-08-01), Prior et al.
patent: 6110484 (2000-08-01), Sierra
patent: 6248763 (2001-06-01), Scivoletto
patent: 6436061 (2002-08-01), Costantino
patent: 6475500 (2002-11-01), Vatter et al.
patent: 6524598 (2003-02-01), Sunkel et al.
patent: 6726674 (2004-04-01), Leu
patent: 2002/0010418 (2002-01-01), Lary et al.
patent: 2002/0077589 (2002-06-01), Tessari
patent: 2003/0120201 (2003-06-01), Abergel
patent: 2003/0190336 (2003-10-01), Adams et al.
patent: 2004/0043052 (2004-03-01), Hunter et al.
patent: 2004/0086474 (2004-05-01), Rabe et al.
patent: 2004/0091543 (2004-05-01), Bell et al.
patent: 2004/0161435 (2004-08-01), Gupta
patent: 2004/0219214 (2004-11-01), Gravett et al.
patent: 2004/0225077 (2004-11-01), Gravett et al.
patent: 2004/0228821 (2004-11-01), Sunkel et al.
patent: 2004/0231070 (2004-11-01), Morrissey et al.
patent: 2005/0107738 (2005-05-01), Slater et al.
patent: 2005/0113768 (2005-05-01), Slater et al.
patent: WO 90/13260 (1990-11-01), None
patent: WO 2004/045549 (2004-06-01), None
patent: WO 2006/023203 (2006-03-01), None
Ludwick, J. 2002 Grand Rounds Archive, Baylor College of Medicine.
Klasson, D.H., et al. 1966 Angiology 17(6): 369-376.
Pharmaceutical Dosage Forms: Disperse Systems vol. 1, pp. 18-26, 32-42. 46-47. 1996.
Pharmaceutical Dosage Forms: Disperse Systems vol. 3, pp. 163-166. 265-297: 1998.
Gravett David M.
Guan Dechi
Hunter William L.
Liggins Richard T.
Maiti Arpita
Angiotech International AG
Seed IP Law Group PLLC
Tsay Marsha
Weber Jon
LandOfFree
Medical implants and fibrosis-inducing agents does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Medical implants and fibrosis-inducing agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Medical implants and fibrosis-inducing agents will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3815888